(Q39695115)

14 September 2017

Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma (English)

1 reference

14 September 2017

11

Torello Lotti

1 reference

14 September 2017

Vincenzo De Giorgi

1

1 reference

14 September 2017

Pamela Pinzani

2

1 reference

14 September 2017

Francesca Salvianti

3

1 reference

14 September 2017

John Panelos

4

1 reference

14 September 2017

Milena Paglierani

5

1 reference

14 September 2017

Agata Janowska

6

1 reference

14 September 2017

Marta Grazzini

7

1 reference

14 September 2017

Janine Wechsler

8

1 reference

14 September 2017

Claudio Orlando

9

1 reference

14 September 2017

Marco Santucci

10

1 reference

14 September 2017

Mario Pazzagli

12

1 reference

14 September 2017

Daniela Massi

13

1 reference

14 September 2017

language of work or name

English

0 references

publication date

10 June 2010

1 reference

Journal of Investigative Dermatology

14 September 2017

1 reference

14 September 2017

130

1 reference

14 September 2017

10

1 reference

14 September 2017

2440-2447

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2010.141

14 September 2017

0 references

cites work

Circulating tumor cells in solid cancer: tumor marker of clinical relevance?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

The current epidemiology of cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled--polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Diagnosis and treatment of cutaneous melanoma: state of the art 2006.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Prognostic significance of the sequential detection of circulating melanoma cells by RT-PCR in high-risk melanoma patients receiving adjuvant interferon

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Circulating tumor cells: detection, molecular profiling and future prospects

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Molecular markers of circulating melanoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patients

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Circulating tumor cells (CTC) detection: clinical impact and future directions.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Tyrosinase messenger RNA in peripheral blood is related to poor survival in patients with metastatic melanoma following interleukin-2-based immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Molecular staging of malignant melanoma: correlation with clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Molecular staging in stage II and III melanoma patients and its effect on long-term survival.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Enrichment, immunomorphological, and genetic characterization of fetal cells circulating in maternal blood

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Surgical strategies and minimal residual disease detection

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Detection of disseminated tumor cells in peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.141

7 January 2021

Identifiers

DOI

10.1038/JID.2010.141

1 reference

14 September 2017

1 reference